Shilpa Medicare Share Price
Small Cap | Pharmaceuticals and health care | NSE: SHILPAMED | BSE: 530549
₹629.60 
-47.15 (-6.97 %)
Last Updated: 04 Apr 2025 03:59 PM
BEARISH
Overview
Open (₹) 666.50
High (₹) 673.40
Low (₹) 625.00
Prev. Close (₹) 676.75
Volume 2,54,563
VWAP (₹) 611.45
ROCE (%) 6.03
Industry P/E 44.73
TTM P/E 69.72
P/B Ratio 3.02
Market Cap (₹) Cr.6,156.92
Dividend Yield (%)--
EPS (₹) 3.67
ROE1.76%
Sales Growth (%) 9.66
Profit Growth (%)-235.52
Day Range
673.40673.40
52 Week Range
419.10959.95
Historical Returns
Returns (6M)
-16.75 %
Returns (1Y)
26.96 %
Returns (3Y)
47.55 %
Returns (5Y)
122.39 %
Returns (6M)
-16.75 %
Returns (1Y)
26.96 %
Returns (3Y)
47.55 %
Returns (5Y)
122.39 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 47.60
MFI 20.80
ATR 33.07
Commodity Channel Index -141.81
ROC125 -18.45
ROC21 -13.49
Williams %R -94.89
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 621.04 | 631.97 | 640.99 | 612.02 | 601.09 | 592.07 | 581.14 |
| Week Ago | 686.24 | 696.67 | 704.09 | 678.82 | 668.39 | 660.97 | 650.54 |
| Month Ago | 716.71 | 742.93 | 766.31 | 693.33 | 667.11 | 643.73 | 617.51 |
EMA & SMA
629.60
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 652.54
9 Day 652.25
10 Day 649.77
12 Day 655.53
14 Day 661.63
20 Day 679.45
26 Day 695.49
50 Day 746.60
100 Day 796.42
200 Day 728.21
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| THE VANGUARD GROUP INC AC VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND | bulk | Buy | 21 Mar, 2025 | ₹683.03 | 5,47,853 | NSE |
| UBS PRINCIPAL CAPITAL ASIA LIMITED | block | Sell | 23 Jan, 2025 | ₹818.05 | 1,63,006 | NSE |
| UBS AG | block | Buy | 23 Jan, 2025 | ₹818.05 | 1,63,006 | NSE |
| PLUTUS WEALTH MANAGEMENT LLP | bulk | Buy | 05 Jun, 2024 | ₹492.34 | 7,50,000 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 21 Feb, 2024 | ₹444.09 | 4,82,523 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 21 Feb, 2024 | ₹443.95 | 4,82,523 | NSE |
| TA FII INVESTORS LIMITED | bulk | Sell | 20 Feb, 2024 | ₹422.22 | 5,00,000 | NSE |
| TA FII INVESTORS LIMITED | bulk | Sell | 19 Feb, 2024 | ₹407.05 | 13,45,000 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 19 Feb, 2024 | ₹404.48 | 5,78,067 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 19 Feb, 2024 | ₹404.63 | 5,78,067 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 30 Jun, 2023 | ₹273.06 | 7,71,081 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 30 Jun, 2023 | ₹272.92 | 7,71,081 | NSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 13 Dec, 2024 | PRIYA INANI | Disposal | ₹837.45 | 1,00,000 | NSE |
| 26 Sept, 2024 | VISHNUKANT CHATURBHUJ BHUTADA | Pledge | ₹858.00 | 10,00,000 | NSE |
| 26 Sept, 2024 | RAMAKANT INNANI | Pledge | ₹858.00 | 6,75,000 | NSE |
| 26 Sept, 2024 | BRIJGOPAL INNANI | Pledge | ₹858.00 | 2,00,000 | NSE |
| 26 Sept, 2024 | DHARMAVATI BHUTADA | Pledge | ₹858.00 | 6,75,000 | NSE |
| 26 Sept, 2024 | DEEPAK KUMAR INNANI | Pledge | ₹858.00 | 6,75,000 | NSE |
| 26 Sept, 2024 | OMPRAKASH INANI | Pledge | ₹858.00 | 2,00,000 | NSE |
| 25 Sept, 2024 | RAMAKANT INNANI | Pledge | ₹0.00 | 6,75,000 | NSE |
| 25 Sept, 2024 | BRIJGOPAL INNANI | Pledge | ₹ | 2,00,000 | NSE |
| 25 Sept, 2024 | DHARMAVATI BHUTADA | Pledge | ₹0.00 | 6,75,000 | NSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 23 May, 2022 | Rs.1.1000 per share(110%)Dividend | 19 Sept, 2022 | 01 Jan, 1970 |
| 31 May, 2021 | Rs.1.1000 per share(110%)Dividend | 20 Sept, 2021 | 01 Jan, 1970 |
| 03 Mar, 2020 | Rs.1.1000 per share(110%)Interim Dividend | 16 Mar, 2020 | 17 Mar, 2020 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 03 Apr, 2025 | NSE India | Launch of 2nd NDA Bortezomib for injection3.5mg/1.4ml in US |
| 03 Apr, 2025 | BSE India | Launch of 2nd NDA Bortezomib for injection 3.5mg/1.4ml in US |
| 27 Mar, 2025 | NSE India | SHILPA MEDICARE LIMITED has informed the Exchange about Closure of Trading Window |
| 27 Mar, 2025 | NSE India | Shilpa Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 17 Mar, 2025 | NSE India | Shilpa Medicare Limited has informed the Exchange that Shilpa Biologicals Private Limited (''SBPL''), a wholly owned subsidiary of Shilpa Medicare Limited (''Company''), has entered into a binding Term Sheet with mAbTree Biologics AG |
| 17 Mar, 2025 | BSE India | Execution of binding term sheet with mAbTree Biologics AG |
| 14 Mar, 2025 | NSE India | Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit-2 of Shilpa Pharma Lifesciences Limited, a wholly owned subsidiary of Shilpa Medicare Limited. |
| 14 Mar, 2025 | BSE India | USFDA Inspection at Unit 2 of Shilpa Pharma Lifesciences Limited, a wholly owned subsidiary of Shilpa Medicare Limited. |
| 12 Mar, 2025 | NSE India | Shilpa Medicare Limited has informed the Exchange about Intimation for Participation in Investor Conference |
| 07 Mar, 2025 | NSE India | Shilpa Medicare Limited has informed the Exchange about USFDA Inspection at Unit-1 of Shilpa Pharma Lifesciences Limited, a wholly owned subsidiary of Shilpa Medicare Limited |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 04 Feb, 2025 | 10 Feb, 2025 |
| Quarterly Results | -- | 05 Nov, 2024 | 13 Nov, 2024 |
| Quarterly Results | -- | 01 Aug, 2024 | 08 Aug, 2024 |
| Audited Results & Final Dividend | -- | 20 May, 2024 | 23 May, 2024 |
| Quarterly Results | -- | 05 Feb, 2024 | 08 Feb, 2024 |
| Quarterly Results | -- | 06 Nov, 2023 | 10 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 10 Aug, 2023 |
| Rights issue of Equity Shares | -- | 07 Jul, 2023 | 23 Jun, 2023 |
| Audited Results | -- | 18 May, 2023 | 25 May, 2023 |
| Quarterly Results | -- | 06 Feb, 2023 | 14 Feb, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 44.23% | 50.01% | 50.01% | 50.01% | 53.25% |
| Foreign Institutions + | 9.9% | 8.52% | 15.32% | 14.59% | 16.21% |
| Domestic Institutions + | 8.27% | 0.06% | 0.61% | 2.87% | 3.24% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 37.6% | 41.41% | 34.06% | 32.53% | 27.3% |
| Others | 0% | 0% | 0% | 0% | 0% |
About Shilpa Medicare
Shilpa Medicare is a Public Limited Listed company incorporated on 20/11/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008739 and registration number is 008739. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 309.79 Cr. and Equity Capital is Rs. 8.68 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1987
Managing Director
Mr. Vishnukant C Bhutada
NSE Symbol
SHILPAMED
Shilpa Medicare Management
| Name | Designation |
|---|---|
| Mr. Omprakash Inani | Chairman |
| Mr. Vishnukant C Bhutada | Managing Director |
| Mr. Kalakota Sharath Reddy | Whole Time Director |
| Mr. Hetal Madhukant Gandhi | Independent Director |
| Mr. Arvind Vasudeva | Independent Director |
| Dr. Kamal K Sharma | Independent Director |
| Dr. Anita Bandyopadhyay | Independent Woman Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35  ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
| Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50  ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on Shilpa Medicare
What is the share price of Shilpa Medicare?
The share price of Shilpa Medicare on 04 Apr, 2025 is ₹ 629.60.
What is 52W high and 52W low share price of Shilpa Medicare?
The highest and lowest 52W share prices of Shilpa Medicare are ₹ 959.950 and ₹ 419.100
What is the market cap of Shilpa Medicare?
The market capitalization of Shilpa Medicare as of 04 Apr, 2025 is ₹ 6,156.92 Crores
What is the P/E ratio of Shilpa Medicare?
The current P/E ratio of Shilpa Medicare as of 04 Apr, 2025 is 44.73
What is the PB ratio of Shilpa Medicare?
The PB ratio of Shilpa Medicare as of 04 Apr, 2025 is 3.02
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)